Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01839903 · ClinicalTrials.gov registry record · NA

System Based Tracking and Treatment for Emergency Patients Who Smoke: STTEPS

A NA study of Tobacco Dependence, sponsored by The Miriam Hospital.

Completed
Registry status
NA
Development phase
444
Enrollment target
2
Study locations

NCT01839903: Completed NA study of Tobacco Dependence, sponsored by The Miriam Hospital.

NCT01839903 is a NA study of Tobacco Dependence that has completed, run by The Miriam Hospital. The registered enrollment target is 444 participants, roughly in line with the 463-participant average among 28 other Tobacco Dependence trials with a reported enrollment target. The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01839903, a NA study of Tobacco Dependence, has completed, sponsored by The Miriam Hospital.

COMPLETED
Registry status
NA
Development phase
444 participants
Enrollment target
2
Study locations

Study Summary

Emergency Departments (EDs) are a critical component of the U.S. healthcare system, treating over 119 million patients each year. While EDs have historically neglected tobacco control efforts, several recent studies have examined the feasibility and efficacy of implementing tobacco cessation in the ED. Work by our research team and others, has shown that tobacco treatment is both feasible and effective in the ED setting. Effective, evidence-based interventions for treating tobacco dependence have also been codified in the United States Public Health Service guidelines. Even brief interventions delivered by physicians and other healthcare providers can produce significant increases in cessation across diverse clinical settings (e.g., outpatient clinics, surgery units, EDs), and patient groups (cardiac, respiratory, general admissions). However, in clinical practice, delivery of tobacco interventions is inconsistent at best, particularly in non-primary care settings. This translational study uses an existing Emergency Department Information System (EDIS), to facilitate the identification of smokers and to enhance the provision of smoking cessation intervention materials and pharmacological adjuncts for patients receiving treatment in the ED. The EDIS tracks the geographic and chronologic progression of patients through the ED and contains triage and nursing notes, lab values, radiology reports and links to images, vital signs, embedded printable discharge instructions, and fax links to primary care provider (PCP) offices. Following recruitment of a baseline (care-as-usual) cohort (Step 1), the investigators will provide training to ED physicians and staff to improve the identification and treatment of smokers. Following Step 1, the investigators will make adaptations to the EDIS system that include smoking status tracking, tobacco treatment prompts and medication information panels for the emergency treating physician, and links to printable discharge instructions,

Primary Outcome

Smoking abstinence at 6 month follow up. Abstinence is determined by Cotinine validated 7-day point prevalence abstinence at each follow up (24 hour, 3 month, 6, month)

Conditions Studied

Interventions

  • OTHER EDIS
  • OTHER Care as usual

Study Locations (2)

Massachusetts

  • University of Massachusetts Medical School - Worcester

Rhode Island

  • Rhode Island Hospital - Providence

Trial Details

FieldValue
Enrollment Target 444 participants
Start Date 2011-08-19
Est. Completion 2017-06-30
Phase NA
The Miriam Hospital

136 total trials

What the finished NCT01839903 record still lists

NCT01839903 is an interventional study that assigns participants to a tested intervention. The registered 444 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 463-participant average among 28 other Tobacco Dependence trials with a reported enrollment target.

The record links to 1 condition, with Tobacco Dependence appearing as the primary indexed condition, and to 2 interventions - of which EDIS is the first listed.

NCT01839903 reports a single indexed study location in Massachusetts, Rhode Island.

Frequently Asked Questions

What is clinical trial NCT01839903 about?

NCT01839903 is a clinical study titled "System Based Tracking and Treatment for Emergency Patients Who Smoke: STTEPS". Emergency Departments (EDs) are a critical component of the U.S. healthcare system, treating over 119 million patients each year. While EDs have historically neglected tobacco control efforts, several recent studies have examined the feasibility and efficacy of implementing tobacco cessation in the ...

What is the current status of trial NCT01839903?

This trial is currently completed. It is a NA study. The enrollment target is 444 participants. The study started on 2011-08-19. Estimated completion is 2017-06-30.

What conditions does trial NCT01839903 study?

This clinical trial studies the following conditions: Tobacco Dependence.

What interventions are being tested in trial NCT01839903?

The interventions under investigation include: EDIS (OTHER), Care as usual (OTHER).

Who is sponsoring clinical trial NCT01839903?

This trial is sponsored by The Miriam Hospital, which has 136 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01839903 being conducted?

This trial has 2 study locations across Massachusetts, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tobacco Dependence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01839903's enrollment target sits among peer trials

444 9th of 28 higher than 20 of 28 other Tobacco Dependence trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Tobacco Dependence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06348394 · 444 participants · NA

    Intracardiac Versus Transesophageal Echocardiographic Guidance for Left Atrial Appendage Occlusion

  • NCT06700343 · 444 participants · Phase 3

    Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)

  • NCT01280994 · 445 participants · Phase 2

    Hyperpolarized 129Xe MRI for Imaging Pulmonary Function

  • NCT03504800 · 445 participants

    OCT in Diagnosis of Irregular Corneas

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01839903, the US trial registry maintained by the National Library of Medicine. NCT01839903 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.